Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionretinoic acid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.17e-05281484GO:0001972
GeneOntologyMolecularFunctionglucuronosyltransferase activity

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.27e-04351484GO:0015020
GeneOntologyMolecularFunctionretinoid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.38e-04481484GO:0005501
GeneOntologyMolecularFunctionisoprenoid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.74e-04491484GO:0019840
GeneOntologyMolecularFunctionsteroid binding

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GC ATP1A2

4.74e-041331486GO:0005496
GeneOntologyMolecularFunctionoligopeptidase activity

NLN MME

5.38e-0451482GO:0070012
GeneOntologyBiologicalProcessestrogen catabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.23e-0851474GO:0006711
GeneOntologyBiologicalProcessphenylpropanoid catabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.67e-0861474GO:0046271
GeneOntologyBiologicalProcesscoumarin catabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.67e-0861474GO:0046226
GeneOntologyBiologicalProcessflavone metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.67e-0861474GO:0051552
GeneOntologyBiologicalProcesshormone catabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9 MME

3.19e-07211475GO:0042447
GeneOntologyBiologicalProcessphenylpropanoid metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.03e-07101474GO:0009698
GeneOntologyBiologicalProcesscoumarin metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.03e-07101474GO:0009804
GeneOntologyBiologicalProcessflavonoid metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.68e-06131474GO:0009812
GeneOntologyBiologicalProcessflavonoid glucuronidation

UGT1A8 UGT1A7 UGT1A9

3.51e-0651473GO:0052696
GeneOntologyBiologicalProcesssteroid catabolic process

CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.05e-06341475GO:0006706
GeneOntologyBiologicalProcessimmunoglobulin mediated immune response

CFH IGHV1-45 SVEP1 FGL2 FCER1A MLH1 IGHV4-38-2 IGHV4-28 IGHV4-4 MASP2

7.40e-0623514710GO:0016064
GeneOntologyBiologicalProcessB cell mediated immunity

CFH IGHV1-45 SVEP1 FGL2 FCER1A MLH1 IGHV4-38-2 IGHV4-28 IGHV4-4 MASP2

1.03e-0524414710GO:0019724
GeneOntologyBiologicalProcesscellular glucuronidation

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.35e-05211474GO:0052695
GeneOntologyBiologicalProcessglucuronate metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.28e-05261474GO:0019585
GeneOntologyBiologicalProcessuronic acid metabolic process

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.28e-05261474GO:0006063
GeneOntologyBiologicalProcessarterial endothelial cell fate commitment

DLL1 RBPJ

5.05e-0521472GO:0060844
GeneOntologyBiologicalProcessxenobiotic glucuronidation

UGT1A8 UGT1A7 UGT1A9

7.44e-05121473GO:0052697
GeneOntologyBiologicalProcessretinoic acid metabolic process

UGT1A8 UGT1A7 UGT1A9 RDH16

1.85e-04401474GO:0042573
GeneOntologyBiologicalProcessblood vessel endothelial cell fate specification

DLL1 RBPJ

3.00e-0441472GO:0097101
GeneOntologyBiologicalProcessblood vessel endothelial cell fate commitment

DLL1 RBPJ

3.00e-0441472GO:0060846
GeneOntologyCellularComponentmembrane raft

TEK DLL1 DLC1 FCER1A SYNJ2 SPRED1 MME ATP1A2 HAS2 ATP1A4 HYAL2

5.23e-0536214711GO:0045121
GeneOntologyCellularComponentmembrane microdomain

TEK DLL1 DLC1 FCER1A SYNJ2 SPRED1 MME ATP1A2 HAS2 ATP1A4 HYAL2

5.50e-0536414711GO:0098857
DomainEGF_2

MATN3 CNTNAP1 LAMA2 TEK DLL1 TENM2 SVEP1 ADAM2 HYAL2 EPHA10 MASP2

4.48e-0626513811PS01186
DomainUDPGT

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.55e-05211384PF00201
DomainUDPGT

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.55e-05211384PS00375
DomainUDP_glucos_trans

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.55e-05211384IPR002213
DomainEGF-like_CS

MATN3 CNTNAP1 LAMA2 TEK DLL1 TENM2 SVEP1 HYAL2 EPHA10 MASP2

2.46e-0526113810IPR013032
DomainEGF

MATN3 CNTNAP1 LAMA2 TEK DLL1 TENM2 SVEP1 HYAL2 MASP2

6.37e-052351389SM00181
DomainEGF_3

MATN3 CNTNAP1 TEK DLL1 TENM2 SVEP1 ADAM2 HYAL2 MASP2

6.37e-052351389PS50026
DomainEGF-like_dom

MATN3 CNTNAP1 LAMA2 TEK DLL1 TENM2 SVEP1 HYAL2 MASP2

9.91e-052491389IPR000742
DomainEGF_1

CNTNAP1 LAMA2 TEK DLL1 TENM2 SVEP1 ADAM2 HYAL2 MASP2

1.19e-042551389PS00022
Domain-

CNTNAP1 LAMA2 ZZEF1 F8 EPHA10

2.06e-047313852.60.120.260
PathwayKEGG_RETINOL_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9 RDH16 RPE65

1.19e-05641136M9488
PathwayWP_ESTROGEN_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.56e-05221134MM15888
PathwayREACTOME_GLUCURONIDATION

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.67e-05241134MM14599
PathwayREACTOME_GLUCURONIDATION

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.35e-05251134M17787
PathwayWP_GLUCURONIDATION

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.35e-05251134MM15820
PathwayKEGG_ASCORBATE_AND_ALDARATE_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.35e-05251134M605
PathwayWP_GLUCURONIDATION

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.11e-05261134M39404
PathwayKEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.91e-05281134M19580
PathwayKEGG_STEROID_HORMONE_BIOSYNTHESIS

CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.65e-05551135M14933
PathwayWP_CODEINE_AND_MORPHINE_METABOLISM

UGT1A10 UGT1A8 UGT1A9

1.71e-04141133M39328
PathwayREACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GSTM3 GCLC

2.17e-041071136MM14595
PathwayREACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GSTM3 GCLC

2.40e-041091136M18788
PathwayKEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GSTM3

2.42e-04701135M16794
PathwayREACTOME_PARACETAMOL_ADME

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.59e-04391134MM15695
PathwayKEGG_DRUG_METABOLISM_CYTOCHROME_P450

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GSTM3

2.76e-04721135M9257
PathwayKEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.15e-04411134M7399
PathwayREACTOME_BIOLOGICAL_OXIDATIONS

AOC1 CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 GSTM3 GCLC

3.78e-042191138MM14838
PathwayREACTOME_BIOLOGICAL_OXIDATIONS

AOC1 CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 GSTM3 GCLC

3.89e-042201138M10320
PathwayREACTOME_ASPIRIN_ADME

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.53e-04451134MM15694
PathwayKEGG_DRUG_METABOLISM_OTHER_ENZYMES

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.32e-04511134M17726
PathwayKEGG_STARCH_AND_SUCROSE_METABOLISM

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.88e-04521134M14171
PathwayBIOCARTA_NOTCH_PATHWAY

DLL1 RBPJ

9.35e-0461132MM1584
PathwayBIOCARTA_NOTCH_PATHWAY

DLL1 RBPJ

9.35e-0461132M22074
PathwayWP_NRF2_PATHWAY

UGT1A7 UGT1A9 TXNRD1 GSTM3 GCLC SLC5A6

9.46e-041411136M39454
Pubmed

Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.69e-096148432527940
Pubmed

Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.69e-096148420297805
Pubmed

Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.09e-08714848467709
Pubmed

Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferases (mUGTBr/p).

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.09e-08714848464825
Pubmed

Cyp3a11-mediated testosterone-6β-hydroxylation decreased, while UGT1a9-mediated propofol O-glucuronidation increased, in mice with diabetes mellitus.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.09e-087148427514509
Pubmed

Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.17e-088148420610558
Pubmed

Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.17e-088148418052087
Pubmed

Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.17e-088148417179145
Pubmed

A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: The Cardiovascular Risk in Young Finns Study.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.90e-089148422511988
Pubmed

Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.48e-0810148423642732
Pubmed

UDP-glucuronosyltransferases.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.48e-0810148411465080
Pubmed

A genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese population.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.48e-0810148423371916
Pubmed

A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.48e-0810148422558097
Pubmed

Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters: differential regulation through an interior-like region.

UGT1A10 UGT1A8 UGT1A9

7.55e-083148312847094
Pubmed

Cooperative Regulation of Intestinal UDP-Glucuronosyltransferases 1A8, -1A9, and 1A10 by CDX2 and HNF4α Is Mediated by a Novel Composite Regulatory Element.

UGT1A10 UGT1A8 UGT1A9

7.55e-083148329519853
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

FAM47A NEMP1 MYH3 MUC19 UGT1A9 ECPAS ZZEF1 DSCAML1 KY FREM2 MDN1 RDH16 ADAMTS9 SYDE2 TMPO RPE65

1.13e-077361481629676528
Pubmed

Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-0712148420308471
Pubmed

Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-0712148419419973
Pubmed

Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-0712148411434514
Pubmed

UGT1A1 is a major locus influencing bilirubin levels in African Americans.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.18e-0713148422085899
Pubmed

Genome-wide analysis of hepatic lipid content in extreme obesity.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.18e-0713148425246029
Pubmed

Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28.

UGT1A10 UGT1A7 UGT1A9

3.01e-074148317558305
Pubmed

Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.05e-0714148421646302
Pubmed

Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.05e-0714148410836148
Pubmed

The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.05e-071414849295054
Pubmed

Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.05e-0714148414672974
Pubmed

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GSTM3 SLC5A6

3.95e-0766148619898482
Pubmed

Genome-wide association meta-analysis for total serum bilirubin levels.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.51e-0716148419414484
Pubmed

Genome-wide association of serum bilirubin levels in Korean population.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.18e-0717148420639394
Pubmed

Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.

UGT1A8 UGT1A7 UGT1A9

7.50e-075148320565459
Pubmed

Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.

UGT1A10 UGT1A8 UGT1A9

7.50e-075148315057901
Pubmed

Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.20e-0718148420056724
Pubmed

A genome-wide assessment of variability in human serum metabolism.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.16e-0619148423281178
Pubmed

Genome-wide association study of circulating vitamin D levels.

ACADSB GC NADSYN1

1.50e-066148320418485
Pubmed

Genetic determinants influencing human serum metabolome among African Americans.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.13e-0624148424625756
Pubmed

Family-based genome-wide association scan of attention-deficit/hyperactivity disorder.

UGT1A10 UGT1A8 UGT1A9

6.23e-069148320732626
Pubmed

Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.

UGT1A8 UGT1A7 UGT1A9

1.22e-0511148318695635
Pubmed

Human down syndrome cell adhesion molecules (DSCAMs) are functionally conserved with Drosophila Dscam[TM1] isoforms in controlling neurodevelopment.

DSCAM DSCAML1

1.80e-052148221645617
Pubmed

Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene.

UGT1A7 UGT1A9

1.80e-052148211677206
Pubmed

Use of somatic mutations to quantify random contributions to mouse development.

POLD1 MLH1

1.80e-052148223327737
Pubmed

Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.

UGT1A10 UGT1A8

1.80e-052148210497143
Pubmed

Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.

UGT1A7 UGT1A9

1.80e-052148212944498
Pubmed

Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

MUC19 CTSS

1.80e-052148212163455
Pubmed

Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity.

F8 DLC1

1.80e-052148224553346
Pubmed

Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.

UGT1A7 UGT1A9

1.80e-052148217529886
Pubmed

Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10.

UGT1A10 UGT1A9

1.80e-052148225547628
Pubmed

The Na,K-ATPase alpha4 gene (Atp1a4) encodes a ouabain-resistant alpha subunit and is tightly linked to the alpha2 gene (Atp1a2) on mouse chromosome 1.

ATP1A2 ATP1A4

1.80e-052148210555956
Pubmed

Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues.

UGT1A10 UGT1A8

1.80e-052148211901093
Pubmed

DSCAM and DSCAML1 regulate the radial migration and callosal projection in developing cerebral cortex.

DSCAM DSCAML1

1.80e-052148225451118
Pubmed

Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis.

GC DLL1

1.80e-052148229856234
Pubmed

Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.

UGT1A10 UGT1A9

1.80e-052148222031623
Pubmed

Mammalian DSCAMs: roles in the development of the spinal cord, cortex, and cerebellum?

DSCAM DSCAML1

1.80e-052148212051741
Pubmed

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

GRIN2A TRRAP

1.80e-052148221499247
Pubmed

Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors.

UGT1A8 UGT1A9

1.80e-052148218568343
Pubmed

Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes.

UGT1A10 UGT1A8

1.80e-052148217603215
Pubmed

UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.

UGT1A7 UGT1A9

1.80e-052148215709193
Pubmed

Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon.

UGT1A10 UGT1A8

1.80e-05214829647757
Pubmed

How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?

UGT1A10 UGT1A9

1.80e-052148220089735
Pubmed

SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma.

TEK SVEP1

1.80e-052148233027505
Pubmed

An atlas of genetic influences on human blood metabolites.

AOC1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SLC5A6 GADL1

1.82e-05190148724816252
Pubmed

Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation.

ADAMTS9 RBPJ HAS2 HYAL2

2.08e-0538148429743679
Pubmed

Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis.

TEK ADAMTS9 HAS2 HYAL2

2.08e-0538148418267097
Pubmed

Transcription mapping and expression analysis of candidate genes in the vicinity of the mouse Loop-tail mutation.

FCER1A ATP1A2 ATP1A4

2.09e-0513148310920231
Pubmed

Discovery and refinement of loci associated with lipid levels.

EHBP1 AOC1 CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.55e-05211148724097068
Pubmed

Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.

DDX19B POLR2B DNM1L VTA1 ECPAS NLN NADSYN1 GCLC

5.08e-05304148832235678
Pubmed

Expression of vascular endothelial growth factor, CD10, and factor 8 in phyllodes tumor: A 5-year study of 38 cases.

F8 MME

5.38e-053148233342805
Pubmed

Disruption of Notch signaling aggravates irradiation-induced bone marrow injury, which is ameliorated by a soluble Dll1 ligand through Csf2rb2 upregulation.

DLL1 RBPJ

5.38e-053148227188577
Pubmed

Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.

UGT1A7 UGT1A9

5.38e-053148216636344
Pubmed

Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.

UGT1A10 UGT1A9

5.38e-053148220007669
Pubmed

Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites.

UGT1A10 UGT1A8

5.38e-053148219244109
Pubmed

Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.

HAS2 HYAL2

5.38e-053148221743962
Pubmed

UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.

UGT1A8 UGT1A9

5.38e-053148219225446
Pubmed

Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer.

UGT1A7 UGT1A9

5.38e-053148217406868
Pubmed

Replacing the PDZ-interacting C-termini of DSCAM and DSCAML1 with epitope tags causes different phenotypic severity in different cell populations.

DSCAM DSCAML1

5.38e-053148227637097
Pubmed

Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions.

UGT1A8 UGT1A7

5.38e-053148219996319
Pubmed

Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan.

UGT1A7 UGT1A9

5.38e-053148219364970
Pubmed

Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche.

DLL1 RBPJ

5.38e-053148229773667
Pubmed

Genetic polymorphisms of UGT1A8, UGT1A9 and HNF-1α and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid.

UGT1A8 UGT1A9

5.38e-053148223721685
Pubmed

Raloxifene glucuronidation in liver and intestinal microsomes of humans and monkeys: contribution of UGT1A1, UGT1A8 and UGT1A9.

UGT1A8 UGT1A9

5.38e-053148226247833
Pubmed

The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers.

UGT1A8 UGT1A9

5.38e-053148217339869
Pubmed

Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations.

UGT1A7 UGT1A9

5.38e-053148224453052
Pubmed

Transmission of survival signals through Delta-like 1 on activated CD4+ T cells.

DLL1 RBPJ

5.38e-053148227659682
Pubmed

[Influence of genetic polymorphisms in UGT1A1, UGT1A7 and UGT1A9 on the pharmacokynetics of irinotecan, SN-38 and SN-38G].

UGT1A7 UGT1A9

5.38e-053148223789755
Pubmed

Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.

CFH MLH1

5.38e-053148217076561
Pubmed

Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.

UGT1A8 UGT1A9

5.38e-053148216397224
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

POLD1 MATN3 POLR2B TBC1D2B GC NEB ECPAS TRRAP MDN1 TMPO

5.70e-054971481036774506
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

ECPAS MDN1 SYNJ2 RALGPS1 PCDHGA8

8.55e-0510414859205841
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

USP36 NEMP1 HECTD4 TBC1D2B ECPAS ZZEF1 SYNJ2 RALGPS1 FAM20B ATP1A2

9.54e-055291481014621295
Pubmed

Human metabolic individuality in biomedical and pharmaceutical research.

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.04e-0457148421886157
Pubmed

System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency.

TXNRD1 GCLC

1.07e-044148220463017
Pubmed

Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients.

UGT1A8 UGT1A9

1.07e-044148218946804
Pubmed

Pathogenicity of lupus anti-ribosomal P antibodies: role of cross-reacting neuronal surface P antigen in glutamatergic transmission and plasticity in a mouse model.

GRIN2A ZZEF1

1.07e-044148225709106
Pubmed

Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia.

ATP1A2 ATP1A4

1.07e-044148221849490
Pubmed

Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis.

CYP7A1 RPE65

1.07e-044148214517541
Pubmed

Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue.

UGT1A10 UGT1A7

1.07e-04414829271343
Pubmed

Genetic polymorphisms of UGT1A8, UGT1A9, UGT2B7 and ABCC2 in Chinese renal transplant recipients and a comparison with other ethnic populations.

UGT1A8 UGT1A9

1.07e-044148223700788
Pubmed

Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins.

HAS2 HYAL2

1.07e-044148220072653
Pubmed

Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1.

UGT1A10 UGT1A9

1.07e-04414822108603
Pubmed

Association of vitamin D-related gene polymorphisms with manifestation of vitamin D deficiency in children.

GC NADSYN1

1.07e-044148222785457
Pubmed

Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients.

UGT1A8 UGT1A9

1.07e-044148220147615
InteractionSYNE1 interactions

DSCAM MAP1B SYNE1 ECPAS TRRAP NUP35 AXDND1 NLN

2.46e-061231418int:SYNE1
Cytoband2q37

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.05e-063114842q37
GeneFamilyUDP glucuronosyltransferases

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.81e-05321004363
GeneFamilyImmunoglobulin like domain containing

A1BG DSCAM PDGFRL VTCN1 TEK DSCAML1 FCER1A

9.82e-051931007594
GeneFamilyATPase Na+/K+ transporting subunits

ATP1A2 ATP1A4

6.25e-04710021208
GeneFamilyFibronectin type III domain containing

DSCAM TEK DSCAML1 EPHA10 MYBPC1

1.95e-031601005555
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

DSCAM PDGFRL DSCAML1 OPCML MYBPC1

2.01e-031611005593
GeneFamilyCathepsins

CTSC CTSS

3.03e-03151002470
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

CFH SVEP1 MASP2

3.87e-035710031179
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH STAG1 MAP1B LAMA2 NEB PPP1R3A RBPJ MME ATP1A2

1.84e-0819514795c86fddd6d0530beecf45ea5ba6b823123847696
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH LAMA2 TEK OPCML SVEP1 FGL2 DLC1 OLFML1

1.92e-07185147800258f458cbf6d36449db95528a6b5038d731d2d
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH LAMA2 TEK OPCML SVEP1 FGL2 DLC1 OLFML1

1.92e-0718514783cd0686a14e734a0f243070ab939adcb4c454478
ToppCellfacs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH LAMA2 TEK OPCML SVEP1 FGL2 DLC1 OLFML1

1.92e-071851478a94694e226856bc5b168464f52d76004145717a5
ToppCellCOVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type

MAP1B LAMA2 TENM2 PPP1R3A DLC1 CLIC5 ADAMTS9 ATP1A2

2.36e-071901478918ad5037881212008f9f69d5df5da91fd01422c
ToppCellTransplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 OLFML1 HAS2

3.48e-072001478954fee8425673e76198be414f5f6c4e3597c1919
ToppCellTransplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 OLFML1 HAS2

3.48e-072001478bfa73bc5f8a6c7de8353ca049a921ef19f7f4437
ToppCellBronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CFH MAP1B PDGFRL CYP7A1 LAMA2 TENM2 OLFML1 MYBPC1

3.48e-07200147829054cf55e88e1ac81a562d8dd9af9b7c749321d
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CFH MAP1B LAMA2 SVEP1 DLC1 HAS2 PCDHGA8

2.41e-061811477c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CFH MAP1B LAMA2 SVEP1 DLC1 HAS2 PCDHGA8

2.41e-061811477c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCellfacs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH SVEP1 LCLAT1 PPP1R3A SYDE2 MME ATP1A2

2.50e-061821477c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCellfacs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH SVEP1 LCLAT1 PPP1R3A SYDE2 MME ATP1A2

2.50e-061821477dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP7A1 NEB DSCAML1 FREM2 OTOGL ATP1A4 EPHA10

2.68e-0618414772cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP7A1 NEB DSCAML1 FREM2 OTOGL ATP1A4 EPHA10

2.68e-0618414772b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYP7A1 NEB DSCAML1 FREM2 OTOGL ATP1A4 EPHA10

2.68e-061841477ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SYNE1 MATN3 CNTNAP1 LAMA2 DLC1 TBC1D1 ATP1A2

3.09e-06188147732f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B SYNE1 LAMA2 GRIN2A SVEP1 MDN1 HAS2

3.32e-061901477048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B SYNE1 LAMA2 GRIN2A SVEP1 MDN1 HAS2

3.32e-0619014771121eb607a984c59fbffe7220837fc178745aa55
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

STAG1 MAP1B LAMA2 RBPJ MME ATP1A2 HAS2

3.43e-0619114777d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFH PDGFRL LAMA2 OPCML SVEP1 OLFML1 ATP1A2

3.55e-0619214777b48df661f61ce494bf6f0b9a74b0422e29c24bf
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFH PDGFRL LAMA2 OPCML SVEP1 OLFML1 ATP1A2

3.55e-06192147732acd89617934016cd135d2cc797e8e79ae1b37f
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CTSC GPR82 FGL2 GCLC RBPJ MS4A6A CTSS

3.80e-0619414777c7091de47359760003e910cfbe63db5c99410d6
ToppCell5'-Adult-SmallIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CTSC FGL2 FCER1A GCLC RBPJ MS4A6A CTSS

3.94e-061951477f289a44010788853d7726d4b5aa75f3c62186c08
ToppCell5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PDGFRL SYNE1 LAMA2 F8 SVEP1 DLC1 ADAMTS9

4.07e-061961477a579211ef14f348d0c5a290553150222dfbf1515
ToppCellIPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class

USP36 ZNF267 DLC1 MDN1 SYNJ2 ADAMTS9 SPRED1

4.35e-061981477b8bd1ba268480f54451648e01631b615a3401144
ToppCellASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 HAS2

4.50e-0619914774d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6
ToppCellASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 HAS2

4.50e-06199147793e85e3731a9ece9aee3eb82c5dfdad331ee62d6
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFH PDGFRL LAMA2 SVEP1 GSTM3 OLFML1 HAS2

4.50e-0619914774e128c705ad36fd840582848f278770f356fcc8b
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFH PDGFRL LAMA2 SVEP1 GSTM3 OLFML1 HAS2

4.50e-0619914774032f03a4165f5f2a90ef1d8315cc743ce9075bb
ToppCellBronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CFH MAP1B PDGFRL CYP7A1 LAMA2 TENM2 MYBPC1

4.50e-06199147745c3b853900d8c3d5965117d904e3714100138bc
ToppCellSkin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.

CFH PDGFRL LAMA2 SVEP1 FGL2 OLFML1 HAS2

4.65e-062001477f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCellLung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 OLFML1

4.65e-0620014771e75d1302c22e1b1666c19c0c9259d5cc8be16d5
ToppCell367C-Fibroblasts-Fibroblast-E|367C / Donor, Lineage, Cell class and subclass (all cells)

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 OLFML1

4.65e-062001477ddfbc004e7bd2fd3f11f046ed8fc049277160547
ToppCellcellseq-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CFH PDGFRL LAMA2 SVEP1 GSTM3 OLFML1 HAS2

4.65e-06200147756536236a7012efdb28f85b40e464f3da3e87ce8
ToppCellcellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CFH PDGFRL LAMA2 SVEP1 GSTM3 OLFML1 HAS2

4.65e-06200147728e5354008adf97b17333f17f8cbef930db6729a
ToppCelldistal-1-mesenchymal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CFH MAP1B PDGFRL SVEP1 GSTM3 OLFML1 HAS2

4.65e-0620014777623f82bd85a0ff7e2097e9281551208dfc602a8
ToppCell367C-Fibroblasts-Fibroblast-E-|367C / Donor, Lineage, Cell class and subclass (all cells)

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 OLFML1

4.65e-06200147757b9d6aa2265ab178a5886f36ecc66115bd382a8
ToppCellParenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

CFH PDGFRL LAMA2 SVEP1 GSTM3 OLFML1 HAS2

4.65e-062001477fc3c4778841c4b8bac0afb458352614b2c460617
ToppCellParenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 OLFML1

4.65e-0620014770a86656d48e4238d0e4d592d477d29f7ba7c2ec0
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 OLFML1

4.65e-0620014773fa7d9ea67f9cc55478d085da53babd03dbe9bb1
ToppCell(5)_Fibroblast-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

CFH MAP1B PDGFRL LAMA2 SVEP1 GSTM3 OLFML1

4.65e-06200147775e5ecb05e965e24d569aa2ef5cdf740b1528c06
ToppCellSmart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CFH MAP1B GPR82 DLL1 ZFYVE9 MLH1

9.88e-061481476f90ee6fbd71b5e0512af34867202f38409f4de38
ToppCellfacs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EHBP1 GRIN2A TENM2 FREM2 ATP1A2 MASP2

1.43e-0515814768c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCellfacs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EHBP1 GRIN2A TENM2 FREM2 ATP1A2 MASP2

1.43e-051581476f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MUC19 LAMA2 DSCAML1 SVEP1 RDH16 MME

1.54e-051601476c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCelldroplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ISCA1 HECTD4 NEB TENM2 PPP1R3A FCER1A

1.54e-051601476fc76337ad766c859db390ef8b6fb9caeaace3a56
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MUC19 LAMA2 DSCAML1 SVEP1 RDH16 MME

1.54e-05160147625c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCelldroplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ISCA1 HECTD4 NEB TENM2 PPP1R3A FCER1A

1.54e-05160147667ee7a314d7d4d3ea206e0158083f36f6dd7e80b
ToppCelldroplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ISCA1 HECTD4 NEB TENM2 PPP1R3A FCER1A

1.54e-051601476759749f708c3a2b36692d42499f19aff937e592f
ToppCell5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GPR82 FGL2 FCER1A P2RY1 DNAH17 MS4A6A

1.96e-0516714761bd0aa7a3c8649f342bb856cf861c4c5984ad889
ToppCellfrontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CFH PDGFRL SVEP1 FGL2 ADAMTS9 ATP1A2

2.03e-0516814769930bd63b60c03f0152838a79eef77da1c2dd8e5
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B TENM2 AXDND1 CLIC5 MME ARHGEF3

2.17e-05170147660bbd738c12e64e483485586c30057304884f5a6
ToppCellnormal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CFH FNBP1 GPR82 ZFY CD3D MASP2

2.24e-05171147661318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CFH MAP1B LAMA2 GRIN2A SVEP1 ATP1A2

2.32e-051721476ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CFH MAP1B LAMA2 GRIN2A SVEP1 ATP1A2

2.32e-0517214761ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCell5'-Adult-Distal_Rectal-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NEB FGL2 FCER1A JCHAIN MS4A6A IGHV4-28

2.39e-051731476b335ca2a247156eba821943b2b9fc9922230b409
ToppCellsevere_influenza-Plasmablast|severe_influenza / disease group, cell group and cell class (v2)

CCDC168 IGLV6-57 CLIC5 JCHAIN MANSC4 IGHV4-4

2.47e-0517414768c6c4d794373e774ecb3382cb7163b4246b98780
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AOC1 FGL2 FCER1A RBPJ SPRED1 MS4A6A

2.55e-051751476f5822cf48777880e670a6a18158ffb31d066c24a
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AOC1 FGL2 FCER1A RBPJ SPRED1 MS4A6A

2.55e-051751476cddbd42c1cdfcdf2a41d96198ddb20e684ee6317
ToppCellsevere_influenza-Plasmablast|World / disease group, cell group and cell class (v2)

CCDC168 IGLV6-57 CLIC5 JCHAIN MANSC4 IGHV4-4

2.55e-051751476e6d6c44510d5dc4eb0bae820125e42366f7a4e74
ToppCell3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

AOC1 FGL2 FCER1A RBPJ SPRED1 MS4A6A

2.55e-051751476067f77c5d9ae3cf960b84ece80c25d5193873cbf
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CFH MAP1B LAMA2 GRIN2A SVEP1 DLC1

2.81e-051781476d4ecb84e9b1f4ec49c519321156aa10f9bd34cce
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

LCORL LAMA2 CCDC168 ADAMTS9 OTOGL MME

2.81e-0517814760e1bedf991189d0ef9b40dac9281bdf4739333a1
ToppCell5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SYNE1 F8 FGL2 DLC1 ADAMTS9 HYAL2

3.18e-051821476fd786c88826ad3d5cc5c3d80f8e392d6be1b5267
ToppCellCOVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

MAP1B LAMA2 F8 SVEP1 DLC1 ADAMTS9

3.18e-051821476fbd5e332df73bf7141c822fa67b76367dc962017
ToppCellwk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

CFH LCORL KMT5A MATN3 STK26 DSCAML1

3.18e-05182147600a148b1e499bf16325491536d187d4dd6b70c06
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH LAMA2 TEK OPCML SVEP1 FGL2

3.28e-0518314765cfcd589a480e67654d3d94e71916f122150db10
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH LAMA2 TEK OPCML SVEP1 FGL2

3.28e-051831476c3ea8d3b916ffcaca3156e0d77a952724554c4ab
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TENM2 CLIC5 SYNJ2 ADAMTS9 MME ARHGEF3

3.28e-051831476eb559ae3ae252d9365c24ef557dd49b78ed6d898
ToppCellfacs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH LAMA2 TEK OPCML SVEP1 FGL2

3.28e-05183147681003ddc24164959dd41bb12fcac72638789b8f2
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TENM2 CLIC5 SYNJ2 ADAMTS9 MME ARHGEF3

3.28e-051831476612d93df03252d4d2ccdce5a9bc162cfd9172a1a
ToppCell5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SYNE1 F8 FGL2 DLC1 ADAMTS9 HYAL2

3.38e-051841476453295362888c9a59d0e73c7a5b15914c50ff591
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9

LRP12 LAMA2 TEK SVEP1 FGL2 P2RY1

3.38e-05184147667164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCellfacs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRL LAMA2 SVEP1 CLIC5 OLFML1 ATP1A2

3.48e-051851476049d793d043d5d434f143025de49dd210d18756c
ToppCellfacs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRL LAMA2 SVEP1 CLIC5 OLFML1 ATP1A2

3.48e-0518514768433a337625ff8398520e223ef92bf9bb0beb14c
ToppCellfacs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDGFRL LAMA2 SVEP1 CLIC5 OLFML1 ATP1A2

3.48e-05185147663200c42565eea596f9b00728e70e544b8d50a7f
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MAP1B TENM2 AXDND1 CLIC5 MME ARHGEF3

3.59e-0518614761094c7140131454b2583200e1c01e81ccab3db23
ToppCell343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

CFH CTSC CNTNAP1 RBPJ SPRED1 MS4A6A

3.59e-0518614769673367cb53bafb873a01ef6bda11d9f392ce648
ToppCellLPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MAP1B SYNE1 TENM2 PPP1R3A ATP1A2 RPE65

3.59e-0518614764780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SYNE1 MATN3 LAMA2 DLC1 TBC1D1 ATP1A2

3.70e-05187147615d6e158562d7d85af3ceaf955439b379c8fce81
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SYNE1 MATN3 LAMA2 DLC1 TBC1D1 ATP1A2

3.70e-051871476f62074b631fd45ad299c69d71b09267b04d656ee
ToppCelldroplet-Lung-LUNG-30m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYNE1 TEK DLL1 DLC1 CLIC5 HYAL2

3.70e-05187147652ffd4be374e329ac8d321063f061b826d252956
ToppCell10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

CFH CCDC168 NEB DLL1 CD3D SYDE2

3.70e-051871476f31d865ce2a21bdf64dbe29ee3e4505ab482604a
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

MAP1B TEK F8 DSCAML1 ADAMTS9 HYAL2

3.81e-051881476aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCellfacs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 OPCML SVEP1 FGL2 OLFML1 ATP1A2

3.93e-05189147629287525120be2953b76881ba3cfc4379c265e7a
ToppCellfacs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 OPCML SVEP1 FGL2 OLFML1 ATP1A2

3.93e-0518914767150dad9a92a715487c2d8130fa01b752ea69663
ToppCellfacs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LAMA2 OPCML SVEP1 FGL2 OLFML1 ATP1A2

3.93e-0518914766e4c0effd5192fd00052abc048fdb87a74fb6554
ToppCell3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue

GPR82 FGL2 FCER1A ATP1A2 MS4A6A MYBPC1

4.04e-051901476468525c05e38158a3b8a445882b2d63dfb1d2c63
ToppCelldroplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SYNE1 TEK DLL1 DLC1 CLIC5 HYAL2

4.04e-051901476e64b191f928935484e2c993d7f8af0572a617a3a
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FNBP1 STK26 FAM111B CD3D CLIC5 TMPO

4.16e-051911476912e2d10d3423aa7f708fcf2b11da1845f12d7d3
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

FNBP1 STK26 FAM111B CD3D CLIC5 TMPO

4.16e-05191147677a2746b6d9c53b08d4405411c16fcc5a6c734ce
ToppCelldroplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFH LAMA2 SVEP1 OLFML1 MME ATP1A2

4.16e-05191147636467322096bc766cd777dae3bfb4e65511e492c
ToppCelldroplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFH LAMA2 SVEP1 OLFML1 MME ATP1A2

4.16e-05191147694795daf05061baa3b72a1b01c9e940af86de044
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CFH MAP1B LAMA2 GRIN2A SVEP1 DLC1

4.29e-051921476bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCellfacs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH PDGFRL LAMA2 SVEP1 OLFML1 ATP1A2

4.29e-051921476a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCelldroplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFH PDGFRL LAMA2 SVEP1 OLFML1 ATP1A2

4.29e-051921476f9fb24457999dc9e751a099d7f995543b9330ad4
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CFH MAP1B LAMA2 GRIN2A SVEP1 DLC1

4.29e-0519214760ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CFH MAP1B LAMA2 GRIN2A SVEP1 DLC1

4.29e-051921476d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCellfacs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CFH PDGFRL LAMA2 SVEP1 OLFML1 ATP1A2

4.29e-051921476eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCelldroplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CFH PDGFRL LAMA2 PPP1R3A OLFML1 ATP1A2

4.29e-0519214761b228f0929b505de82a39bf64c837887b0e56701
Drugnaringenin chalcone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.42e-0951434ctd:C027329
Druganthrarobin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.42e-0951434ctd:C032186
DrugDCNB

UGT1A10 UGT1A8 UGT1A7 CTSC UGT1A9 GSTM3 GCLC MME HAS2

8.77e-09951439CID000007443
Drug1,2,5,8-tetrahydroxy anthraquinone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.22e-0861434ctd:C543211
Drugalloin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.22e-0861434ctd:C006457
Drug2',5'-dihydroxychalcone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.22e-0861434ctd:C107497
Drug2',4'-dihydroxychalcone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.15e-0871434ctd:C059354
Druganisole

UGT1A10 UGT1A8 SYNE1 UGT1A7 UGT1A9 ATP6V0A2

9.21e-08361436CID000007519
Drug1,4-dihydroxyanthraquinone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.02e-0781434ctd:C034890
DrugAC1MRQNQ

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.83e-0791434CID003522271
DrugDHPASiU

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.83e-0791434CID000197602
Drug3-iodophenol

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.83e-0791434CID000012272
DrugAC1L4J7U

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.83e-0791434CID000186631
DrugChebi:32663

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.83e-0791434CID005460873
Drugamonafide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 MLH1

2.20e-07221435CID000050515
DrugN-methylpiperazine

UGT1A10 UGT1A8 SYNE1 UGT1A7 UGT1A9

2.20e-07221435CID000053167
Drugplumbagin

UGT1A10 UGT1A8 UGT1A7 UGT1A9 TXNRD1

2.20e-07221435ctd:C014758
Drug2,6-dihydroxyanthraquinone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.04e-07101434ctd:C034889
Drug4-nitrophenyl)imidazole

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.76e-07111434CID000123155
DrugAC1O5XMV

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.76e-07111434CID006442661
DrugThymol

DSCAM UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.39e-07261435ctd:D013943
DrugDiMeIQx

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GSTM3

6.58e-07271435CID000104739
DrugN-OH-DABZ

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.10e-07121434CID000051366
Drug1-O-beta-D-glucopyranosyl-D-mannitol

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.10e-07121434CID000088735
Drug4-hydroxyestrone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.10e-07121434ctd:C026418
Drug2,4,6-TCB

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.10e-07121434CID000037247
Drugnonanoyl-N-methylglucamide

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.10e-07121434CID000160090
Drug7,7,7-triphenylheptanoic acid

UGT1A10 UGT1A8 UGT1A7 UGT1A9

7.10e-07121434CID000276709
Drug7-hydroxycoumarin glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

9.58e-07291435CID000125641
Drughydratropic acid

UGT1A10 UGT1A8 UGT1A7

9.66e-0741433ctd:C013025
Drug2-vanillin

UGT1A10 UGT1A8 UGT1A7

9.66e-0741433ctd:C060843
Drugdiphenylacetic acid

UGT1A10 UGT1A8 UGT1A7

9.66e-0741433ctd:C037760
Drug2-hydroxyestrone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.02e-06131434ctd:C024980
Drugtritanol

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.02e-06131434CID000006457
Drug5-azido-UDP-glucuronic acid

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.02e-06131434CID003081279
Drugcotinine-N-glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.02e-06131434CID000000411
Drugalizarin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.02e-06131434ctd:C010078
Drugparicalcitol

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GC

1.14e-06301435CID005281104
Drugpropranolol glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.42e-06141434CID000119515
DrugPCB-61

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.42e-06141434CID000036401
Drugindole-2-carboxylic acid

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GRIN2A

1.60e-06321435CID000072899
DrugBP-3,6-quinol

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

1.88e-06331435CID000119292
Druggeniposide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GCLC

1.88e-06331435CID000107848
Drugacetaminophen glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GCLC HAS2

1.89e-06591436CID000083944
Drug2,2',3,5,5'-pentachlorobiphenyl

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.93e-06151434CID000040469
Drugafloqualone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.93e-06151434CID000002040
Drugnaphthyl sulphate

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.93e-06151434CID000114775
Drugcoumarin-3-carboxylic acid

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.93e-06151434CID000010752
Drugbergamottin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.93e-06151434ctd:C068337
Drugsulforaphane nitrile

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.93e-06151434CID000543743
Drugisovaleric acid

UGT1A10 UGT1A8 UGT1A7

2.40e-0651433ctd:C008216
Drugbiphenylylacetic acid

UGT1A10 UGT1A8 UGT1A7

2.40e-0651433ctd:C012776
DrugAC1NOWCJ

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

2.54e-06351435CID005120112
Drug3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

2.54e-06351435CID010436171
Drugquercetin-3,4'-diglucoside

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.56e-06161434CID005320835
Drug1'-hydroxyestragole

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.56e-06161434CID000040003
Drugbilirubin-phosphate

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.56e-06161434CID005497144
Drugglucoraphanin

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GCLC

2.94e-06361435CID000656556
DrugDNCB

UGT1A10 UGT1A8 UGT1A7 UGT1A9 ECPAS GSTM3 GCLC MME HAS2

3.17e-061891439CID000000006
Drug3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.33e-06171434CID000003573
Drug6-hydroxychrysene

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.33e-06171434CID000037766
Drug6beta-hydroxytestosterone

CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.38e-06371435CID000065543
Drugl-borneol

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

3.38e-06371435CID000010049
DrugSureCN12722713

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.26e-06181434CID005488034
Drugethyl-beta-D-6-glucosiduronic acid

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.26e-06181434CID000152226
DrugBr 2

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.26e-06181434CID003060900
Drug2,3,7-trichlorodibenzo-p-dioxin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.26e-06181434CID000036614
DrugApApG

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.26e-06181434CID003081975
DrugC1 11-32

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.26e-06181434CID000443077
DrugC11131

UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.26e-06181434CID000443076
Drug3-phenylpropionic acid

UGT1A10 UGT1A8 UGT1A7

4.79e-0661433ctd:C035253
DrugIndoprofen

UGT1A10 UGT1A8 UGT1A7

4.79e-0661433ctd:D007216
Drugharmol

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

5.02e-06401435CID000068094
Drug9-OH-risperidone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.37e-06191434CID000475100
Drug5alpha-spirostan-3beta-ol

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.37e-06191434CID000091433
Drugalmokalant

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.37e-06191434CID003033962
DrugAC1Q6O8B

CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.69e-06411435CID000000334
DrugPTBP

UGT1A10 UGT1A8 UGT1A7 UGT1A9 TBC1D1

6.43e-06421435CID000007393
Drugtectochrysin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.68e-06201434CID005281954
DrugAC1L1OBF

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.68e-06201434CID000032736
Drug4'-hydroxydiclofenac

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.68e-06201434CID000116545
Drugentacapone

UGT1A10 UGT1A8 UGT1A7 UGT1A9

6.68e-06201434ctd:C071192
Drugandrosterone glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

7.24e-06431435CID000114833
Drug7,8-benzoquinoline

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

7.24e-06431435CID000009191
DrugMS-222

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

8.12e-06441435CID000011400
Drugestriol-16-glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.22e-06211434CID000122281
Drugdulcin

UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.22e-06211434CID000009013
DrugBenzamidoxime hydrochloride

UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.22e-06211434CID000069186
DrugN-benzylformamide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 F8 GCLC

8.41e-06761436CID000080654
Drugmethyl salicylate

UGT1A10 UGT1A8 UGT1A7 TXNRD1 GCLC

9.09e-06451435ctd:C033069
Drugamidoxime

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.20e-05231434CID000465967
Drugestradiol-3-glucuronide

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.20e-05231434CID000066651
Drugphenanthridine

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.20e-05231434CID000009189
Drugacridine

UGT1A10 POLD1 UGT1A8 UGT1A7 UGT1A9 HAS2

1.22e-05811436CID000009215
Drug1-hydroxypyrene

UGT1A10 UGT1A8 UGT1A7 UGT1A9 CLPS

1.26e-05481435CID000021387
Drugsalicylamide

UGT1A10 UGT1A8 UGT1A7 UGT1A9 HAS2

1.26e-05481435CID000005147
Drugretigabine

UGT1A10 UGT1A8 UGT1A7 UGT1A9 KCNQ3

1.26e-05481435CID000121892
Drugpheophytin

CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 F8 GSTM3 GCLC TBC1D1 HAS2

1.29e-0528414310CID000000250
Drugglabridin

UGT1A10 UGT1A8 UGT1A9

1.33e-0581433ctd:C107601
Drugcampestrol

CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.39e-05491435CID000010134
Diseaseprotein-tyrosine kinase 6 measurement

CFH UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.68e-1091395EFO_0020691
Diseasetestis-specific chromodomain protein Y 1 measurement

CFH UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.68e-1091395EFO_0802127
Disease5-hydroxyindole sulfate measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.35e-0951394EFO_0800085
DiseaseN-acetyl-4-chlorophenylalanine measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.35e-0951394EFO_0801060
Diseasenuclear receptor subfamily 1 group D member 2 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.35e-0951394EFO_0801853
Diseaseretinol dehydrogenase 16 measurement

CFH UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.69e-09131395EFO_0802007
DiseaseX-21339 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.63e-0871394EFO_0800808
Diseaseangiopoietin-related protein 1 measurement

CFH UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.76e-08181395EFO_0801382
Diseasevitamin D deficiency

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GC NADSYN1

2.02e-08371396EFO_0003762
DiseaseSuccinimide measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0022118
Diseasecholelithiasis, bilirubin measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0004570, EFO_0004799
DiseaseX-24849 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0800909
Diseasemembrane-associated progesterone receptor component 1 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0802740
DiseaseX-16946 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0800766
DiseaseX-11793--oxidized bilirubin measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0021260
DiseaseX-11530 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0021249
Diseasesulfate of piperine metabolite C16H19NO3 (2) measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0801034
DiseaseX-11522 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0800696
DiseaseX-10458 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0800692
Diseaseserum N-desmethylclozapine measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0600043
Diseaseplasma clozapine measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.25e-0881394EFO_0600038
Diseasetissue factor measurement

CFH UGT1A10 UGT1A8 UGT1A7 UGT1A9

4.13e-08211395EFO_0010623
DiseaseX-11442 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.83e-0891394EFO_0021236
DiseaseX-11441 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.83e-0891394EFO_0021235
Diseasecirculating cell free DNA measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.83e-0891394EFO_0004739
Diseasesulfate of piperine metabolite C18H21NO3 (3) measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.83e-0891394EFO_0801037
Diseasesulfate of piperine metabolite C18H21NO3 (1) measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.83e-0891394EFO_0801036
DiseaseX-11880 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.83e-0891394EFO_0800698
Diseasebilirubin measurement, response to xenobiotic stimulus

UGT1A10 UGT1A8 UGT1A7 UGT1A9

5.83e-0891394EFO_0004570, GO_0009410
DiseaseX-21448 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.69e-08101394EFO_0800816
DiseaseX-23974 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.69e-08101394EFO_0800867
Diseasebilirubin measurement, response to tenofovir

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.69e-08101394EFO_0004570, EFO_0009279
DiseaseUDP-glucuronosyltransferase 1-6 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

9.69e-08101394EFO_0802185
Diseaseindole-3-carboxylate measurement

UGT1A10 UGT1A8 UGT1A9

1.02e-0731393EFO_0800043
Diseaseblood 4-oxo-retinoic acid measurement

UGT1A10 UGT1A8 UGT1A9

1.02e-0731393EFO_0022216
Diseasevitamin D measurement, COVID-19

UGT1A10 UGT1A8 UGT1A7 UGT1A9 GC NADSYN1

1.16e-07491396EFO_0004631, MONDO_0100096
Diseasehistidine betaine (hercynine) measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-07111394EFO_0800972
DiseaseX-21796 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-07111394EFO_0800825
Diseaseinsomnia, bilirubin measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-07111394EFO_0004570, EFO_0004698
Diseasepregnenetriol sulfate measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-07111394EFO_0800586
Diseaseplasma N-desmethylclozapine measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-07111394EFO_0600039
Diseasealdosterone measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.52e-07111394EFO_0010219
Diseasep-cresol glucuronide measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-07121394EFO_0800079
Diseasebiliverdin measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

2.27e-07121394EFO_0021033
Diseasepregnenetriol disulfate measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

3.26e-07131394EFO_0800587
Diseasegallstones

CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SYNJ2 ARHGEF3

8.30e-071081397EFO_0004210
Diseaselow density lipoprotein cholesterol measurement, body fat percentage

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.07e-06171394EFO_0004611, EFO_0007800
DiseaseX-21441 measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.07e-06171394EFO_0800814
Disease3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement

UGT1A10 UGT1A8 UGT1A9

2.02e-0661393EFO_0800566
DiseaseGastric Adenocarcinoma

STK26 GRK6 TRRAP MLH1 EPHA10

2.27e-06451395C0278701
Diseasecholelithiasis

CYP7A1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 SYNJ2

3.87e-06881396EFO_0004799
Diseaseneuroblastoma, cutaneous melanoma

UGT1A10 UGT1A8 UGT1A7 UGT1A9

8.84e-06281394EFO_0000389, EFO_0000621
Diseasexanthurenate measurement

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.02e-05291394EFO_0010551
Diseaseserum metabolite measurement

AOC1 UGT1A10 UGT1A8 UGT1A7 GRK6 UGT1A9 GC TEK GSTM3 CLIC5 SLC5A6 JCHAIN DNAH17 GADL1 EPHA10 SPINK5

1.03e-0594513916EFO_0005653
Diseaseresponse to dolutegravir

UGT1A10 UGT1A8 UGT1A7 UGT1A9

1.17e-05301394EFO_0600017
Diseasebone morphogenetic protein 7 measurement

CFH GRK6 ARHGEF3

1.20e-05101393EFO_0020187
Diseaseindoleacetate measurement

UGT1A10 UGT1A8 UGT1A9

1.20e-05101393EFO_0021015
Diseasepeptidase inhibitor 15 measurement

CFH ARHGEF3

2.20e-0521392EFO_0802851
Diseaseoligophrenin-1 measurement

CFH ARHGEF3

2.20e-0521392EFO_0802830
DiseaseNKG2D ligand 3 measurement

CFH ARHGEF3

2.20e-0521392EFO_0802816
Diseasedesert hedgehog protein n-product measurement

CFH ARHGEF3

2.20e-0521392EFO_0020319
Diseaseeukaryotic translation initiation factor 4 gamma 2 measurement

CFH ARHGEF3

2.20e-0521392EFO_0020367
Diseaseephrin type-a receptor 10 measurement

CFH EPHA10

2.20e-0521392EFO_0020350
Diseasetax1-binding protein 1 measurement

CFH ARHGEF3

2.20e-0521392EFO_0803138
Diseaseleukocyte-specific transcript 1 protein measurement

CFH ARHGEF3

2.20e-0521392EFO_0802707
Diseasekallikrein-15 measurement

CFH ARHGEF3

2.20e-0521392EFO_0802669
DiseaseDnaJ homolog subfamily A member 4 measurement

CFH ARHGEF3

2.20e-0521392EFO_0802486
Diseasevasoactive intestinal peptide measurement

CFH ARHGEF3

2.20e-0521392EFO_0020849
Diseasetyrosine-protein kinase YES measurement

CFH ARHGEF3

2.20e-0521392EFO_0020832
Diseasecysteine--tRNA ligase, cytoplasmic measurement

CFH ARHGEF3

2.20e-0521392EFO_0802445
Diseaseactivator of apoptosis harakiri measurement

CFH ARHGEF3

2.20e-0521392EFO_0802253
Diseaseproliferation-associated protein 2g4 measurement

CFH ARHGEF3

2.20e-0521392EFO_0020658
Diseasekinesin-like protein KIF23 measurement

CFH ARHGEF3

2.20e-0521392EFO_0020522
Diseaserho guanine nucleotide exchange factor 10 measurement

CFH ARHGEF3

2.20e-0521392EFO_0802014
Diseasehistone deacetylase 8 measurement

CFH ARHGEF3

2.20e-0521392EFO_0020453
Diseaseheat shock cognate 71 kda protein measurement

CFH ARHGEF3

2.20e-0521392EFO_0020434
Diseaseinterferon lambda-1 measurement

CFH ARHGEF3

2.20e-0521392EFO_0020485
Diseaseproteasome assembly chaperone 3 measurement

CFH ARHGEF3

2.20e-0521392EFO_0802921
DiseaseX-24588 measurement

UGT1A10 UGT1A8 UGT1A9

2.83e-05131393EFO_0800898
DiseaseDown syndrome (implicated_via_orthology)

DSCAM DSCAML1 SYNJ2

4.47e-05151393DOID:14250 (implicated_via_orthology)
Diseaseeukaryotic translation initiation factor 5A-1 measurement

CFH ARHGEF3

6.59e-0531392EFO_0020370
Diseaseepiregulin measurement

CFH ARHGEF3

6.59e-0531392EFO_0020361
Diseasesmall ubiquitin-related modifier 3 measurement

CFH ARHGEF3

6.59e-0531392EFO_0022025
Diseasechloride intracellular channel protein 5 measurement

CFH CLIC5

6.59e-0531392EFO_0801472
Diseasemyocyte-specific enhancer factor 2C measurement

CFH ARHGEF3

6.59e-0531392EFO_0802770
DiseaseB melanoma antigen 2 measurement

CFH ARHGEF3

6.59e-0531392EFO_0801401
DiseasecAMP-regulated phosphoprotein 19 measurement

CFH ARHGEF3

6.59e-0531392EFO_0020223
DiseaseATP-dependent rna helicase ddx19b measurement

DDX19B ARHGEF3

6.59e-0531392EFO_0020167
Diseasemethionine aminopeptidase 2 measurement

CFH ARHGEF3

6.59e-0531392EFO_0008232
Diseasebenign neonatal seizures (is_implicated_in)

KCNQ3 ATP1A2

6.59e-0531392DOID:14264 (is_implicated_in)
Diseasepolyadenylate-binding protein 4 measurement

CFH ARHGEF3

6.59e-0531392EFO_0801897
Diseasen-terminal Xaa-Pro-Lys N-methyltransferase 1 measurement

CFH ARHGEF3

6.59e-0531392EFO_0801820
Diseaseserine-rich single-pass membrane protein 1 measurement

CFH ARHGEF3

6.59e-0531392EFO_0802056
DiseaseRNA-binding protein 3 measurement

CFH ARHGEF3

6.59e-0531392EFO_0802031
Diseaseinhibitor of growth protein 1 measurement

CFH ARHGEF3

6.59e-0531392EFO_0020471
Diseaseserum gamma-glutamyl transferase measurement

EHBP1 STAG1 LCORL FSIP1 CYP7A1 UGT1A10 UGT1A8 UGT1A7 HECTD4 UGT1A9 TENM2 SYNJ2 GCLC MLH1

1.10e-0491413914EFO_0004532
Diseasefibroblast growth factor 7 measurement

CFH ARHGEF3

1.31e-0441392EFO_0020384
Diseasenuclear protein MDM1 measurement

CFH ARHGEF3

1.31e-0441392EFO_0802822
Diseaseubiquitin-fold modifier-conjugating enzyme 1 measurement

CFH ARHGEF3

1.31e-0441392EFO_0020843
Diseaseprotein jagged-1 measurement

CFH GC

1.31e-0441392EFO_0008271

Protein segments in the cluster

PeptideGeneStartEntry
ATVEDSGTYYCTGKV

FCER1A

166

P12319
YRCNGTDIYKDKEST

CD3D

71

P04234
YKESCEAYRLSGKTS

CNTNAP1

581

P78357
INTKTGESECRYYKE

ARHGEF3

301

Q9NR81
ATEYCNTIEGTAKYI

DNM1L

341

O00429
CVSSSYLGYDCTTDK

ADAM2

606

Q99965
KYYASEIAGQTTSKC

ACADSB

371

P45954
DVYKAGEQVTYTCAT

CFH

1006

P08603
KYRESELCSSSIYHQ

AOC1

626

P19801
TTKYSCYSDAEGLEE

CLIC5

151

Q9NZA1
ETVNVKTVCGYYTSA

GMCL1

206

Q96IK5
SLEGQSCDYASKSYD

RALGPS1

26

Q5JS13
ISIAKSLDYEECSFY

PCDHGA8

301

Q9Y5G5
VADSANYSCVYVDLK

A1BG

366

P04217
KNKTITCYDTTSDEY

P2RY1

196

P47900
LSCDKAEKTLSYYQA

DCDC1

1371

M0R2J8
SYTLEYTKTKGDSDE

ISCA1

61

Q9BUE6
AGYTTSTETCQYLKD

HYAL2

331

Q12891
TYYAHADTLCSVKSE

MDN1

3451

Q9NU22
SSQETTSCYEKIFYG

GPR82

126

Q96P67
ETYKNIESYRACGST

LRP12

111

Q9Y561
CYENISELKYSDDLS

MAP10

691

Q9P2G4
YEGYTLNADKKTCSV

MATN3

376

O15232
DTSTYCYETAEKITR

MAP1B

2036

P46821
FQYLSKTYCVDATRE

KMT5A

316

Q9NQR1
GILSKTYDAASYICE

TMPO

616

P42166
YSTEYETIAACQLKF

RPGRIP1L

686

Q68CZ1
KLSSVTAADTAVYYC

IGHV4-4

101

A0A075B6R2
ESGKATSYAELCSEY

SPINK5

356

Q9NQ38
SVKVSCKASGYTFTY

IGHV1-45

36

A0A0A0MS14
NSDIYSSVLEYTLKC

KY

421

Q8NBH2
RYSDLKTIICNYSET

KCNQ3

676

O43525
HDSYSYKDSKETCAV

LCORL

331

Q8N3X6
YSDYDKTGSICASEN

FREM2

2411

Q5SZK8
SINEAVSSYCTYFIK

LCLAT1

16

Q6UWP7
ETCKSITYSLENKTY

ECPAS

1766

Q5VYK3
TISGLKTEDEADYYC

IGLV6-57

96

P01721
ISLASLEYSDYSKCK

EIF2B1

76

Q14232
EYCQTRDKTSTCDTY

MUC19

676

Q7Z5P9
ISTAKSLDYEECSFY

PCDHGA9

301

Q9Y5G4
DTYVNVGLYSTKTCL

NEMP1

126

O14524
KSRYDSIDSYLSKCG

GCLC

326

P48506
SIDSYLSKCGEKYND

GCLC

331

P48506
IALYATYDDGICKSS

MME

46

P08473
LKYYSESTGQKCSRS

MANSC4

56

A6NHS7
EFTDTSYEEKRYTCG

GSTM3

26

P21266
YAKDDEVICTSFYSK

LAMA2

191

P24043
KVSSCDKNTGDYYED

F8

726

P00451
YLQAEEYSIRSCTKG

NALF2

271

O75949
KLSSVTAVDTAVYYC

IGHV4-28

101

A0A0C4DH34
TCKETFNVYYLETEA

EPHA10

121

Q5JZY3
KLSCTDTSAYETAMY

OR2T27

186

Q8NH04
SENSECSVKTLYGIY

CLPS

61

P04118
DSRCSSQYDYDKLVI

HECTD4

666

Q9Y4D8
QYDSDTSCHYKVELS

HECTD4

2201

Q9Y4D8
VDEKDVTYSYGLGSC

ODF1

181

Q14990
YSSEFSKRLLSTYIC

EXOC7

536

Q9UPT5
KLSSVTAADTAVYYC

IGHV4-38-2

101

P0DP08
LGRCQTYTSEYKSAV

OLFML1

71

Q6UWY5
ESSVKGDFYCNEKYS

PPP1R3A

381

Q16821
VSEKDYGNYTCVATN

OPCML

286

Q14982
GYITSCYKAVNSKDD

PAN3

501

Q58A45
TGCFSYYQEAKSSKI

ATP1A2

141

P50993
LVSCSEIYTGKENYE

ADAMTS9

1636

Q9P2N4
SYEKLYEEVSKCENT

DNAH17

1041

Q9UFH2
EEEEYKYTSCKAFIS

FNBP1

61

Q96RU3
CSTSKDTKYQSVYVI

DLL1

696

O00548
RAVKAEDSGYYTCTA

DSCAML1

1351

Q8TD84
CYDDKYTTLLTDSEN

AXDND1

191

Q5T1B0
TIKQYYVLCSSRDEK

DDX19B

306

Q9UMR2
YATKYTARSKCLTET

HAS2

326

Q92819
KYKEEGSKVTTYCNE

CTSC

106

P53634
EYTKSGYESACKDFV

DHRS12

16

A0PJE2
SSKSTYKVGNYETDT

EHBP1

561

Q8NDI1
YTTDCYTAKASLAGT

MS4A6A

171

Q9H2W1
TTYKAVIQYSCEETF

MASP2

386

O00187
SDKVSNYYKTTSSEI

EFHB

691

Q8N7U6
KDCSDYYAIGKRSSE

FGL2

211

Q14314
LESEECEASKGYYLT

FSIP1

471

Q8NA03
TKECVSDSLQYRYTS

FAM47A

591

Q5JRC9
DSKYRAATCSKYTEL

CTSS

216

P25774
RYLDENGKTKTTFYC

CYP7A1

411

P22680
EDSATETCYTYDRNK

JCHAIN

116

P01591
YDVSYDTGDKSIQCS

GADL1

371

Q6ZQY3
AVYDSGYCVSSIKKL

CCDC168

2851

Q8NDH2
VSVATCEQLTYYSKS

FAM111B

446

Q6SJ93
VVSLAYAYETKDALC

GRK6

246

P43250
ESKYTVENGYSTSAK

POLD1

736

P28340
KTDDDETYCRAATEY

OTOGL

351

Q3ZCN5
TAYKASTSDYQVISD

NUP35

291

Q8NFH5
IRTVKAEDSGYYSCI

DSCAM

1346

O60469
LKSSKEYCTYVVCNA

SYDE2

331

Q5VT97
QSYISEIGRSAKSYC

TAF8

66

Q7Z7C8
EDYYACTETNFITKI

RPE65

141

Q16518
YDAKSDIYSVGITAC

STRADA

256

Q7RTN6
KEYTDCVVTLSAFAT

SYNE1

711

Q8NF91
KYDVGSAAYDTSDKC

SYNJ2

781

O15056
YCISKYGVEAFSDSL

RDH16

176

O75452
ITVLSQCDSSYVTKY

STK26

71

Q9P289
YLSSRTEKAAVLSCY

SLC5A6

281

Q9Y289
DLQEKEVAYCSTYTH

POLR2B

681

P30876
TQKSYSSSETLKAYD

TENM2

36

Q9NT68
TYCFVVDSKEEYAKG

MYH3

36

P11055
SGQCYVTTYELTRKF

SLC25A44

86

Q96H78
TTKTADGKCAYRASY

MLH1

116

P40692
YICRKDEAKTGSTYI

PDGFRL

151

Q15198
FRNTVTYTCKEGYTL

SVEP1

1981

Q4LDE5
TYTCKEGYTLAGLDT

SVEP1

1986

Q4LDE5
YSTSEQAELSYKKVS

DLC1

1346

Q96QB1
TGCFSYYQEAKSSKI

ATP1A4

151

Q13733
EKVDGTCCYVTTYKD

C12orf29

56

Q8N999
ASIGYTYEDSTVAKV

CLASRP

161

Q8N2M8
AASEYAKYCSEILGV

NLN

596

Q9BYT8
RLYAGSTVKCDYENV

TXNRD1

506

Q16881
SEICSTAKESLYYFG

TPTE

356

P56180
IYTTSASKTIRYCEK

ZDHHC20

116

Q5W0Z9
YECGESSKVFKYNSS

ZNF749

751

O43361
NCTVKTYSTSYTLED

UGT1A10

71

Q9HAW8
CKYAGSALQYEDVST

VTA1

276

Q9NP79
DSKKSDYLYSCGDET

SPRED1

286

Q7Z699
EYDESYCDAVKKTSP

FAM20B

251

O75063
DECGKAFSYRSYLTT

ZNF267

691

Q14586
TPQKACDSSSRYEDY

TBC1D1

671

Q86TI0
LCADYSENTFTEYKK

GC

406

P02774
CSKTYSILCSEEYTI

STAG1

636

Q8WVM7
TLYEKFTYAGIDCSA

TEK

1106

Q02763
NCTVKTYSTSYTLED

UGT1A9

71

O60656
NYCTAKTLYISDSDK

RBPJ

121

Q06330
ILSYYDSQDDVCKGS

PLEKHA3

26

Q9HB20
HSGEKTYQYEECAKS

ZNF658

406

Q5TYW1
EECDKAFKYSYTLTT

ZNF626

316

Q68DY1
CTKESYDYLKTLAGD

VPS29

41

Q9UBQ0
LKSVAKCYAYIETSS

ZZEF1

246

O43149
KCYAYIETSSNSADI

ZZEF1

251

O43149
YKCEECGKAYISLSS

ZFP62

561

Q8NB50
SECGKSYSSRSYLAV

ZNF557

176

Q8N988
QYDKYFTSSRLCEGV

TBC1D2B

376

Q9UPU7
SVASKYEELECLYAA

TRRAP

2231

Q9Y4A5
QKRCKYSETATAIAY

TRRAP

2766

Q9Y4A5
YECTECGKTFSKSTY

ZNF805

231

Q5CZA5
KEIEESKSECYSNIY

ZFYVE9

506

O95405
SVCKSVSDTYDPYLD

USP36

256

Q9P275
NCTVKTYSTSYTLED

UGT1A7

71

Q9HAW7
TTHTRDKSYKCSYSV

ZNF175

691

Q9Y473
QLTDAGTYKCYIITS

VTCN1

121

Q7Z7D3
EYCEYSTTDASGFKR

ZFY

746

P08048
NCTVKTYSTSYTLED

UGT1A8

71

Q9HAW9
CKGYTIVSYAELDES

ATP6V0A2

196

Q9Y487
EYNCALTEKKYVTGA

ZW10

121

O43264
YGTSCDKTTAVEYNK

ZNF658B

31

Q4V348
HSGEKTYQYEECAKS

ZNF658B

166

Q4V348
DKSIGYLCTEKSNVY

LEG1

301

Q6P5S2
SLLGYLTKYDCSSAD

NADSYN1

521

Q6IA69
EYYVTAGDEKCSTEL

MYBPC1

321

Q00872
ASKYPKDCSEVERTY

GRIN2A

1091

Q12879
SSRNIASDCKYKEAY

NEB

1566

P20929